(NASDAQ: IRTC) Irhythm Holdings's forecast annual revenue growth rate of 14.22% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.27%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.91%.
Irhythm Holdings's revenue in 2026 is $825,336,000.On average, 17 Wall Street analysts forecast IRTC's revenue for 2026 to be $29,807,784,353, with the lowest IRTC revenue forecast at $28,481,682,742, and the highest IRTC revenue forecast at $30,785,796,652. On average, 17 Wall Street analysts forecast IRTC's revenue for 2027 to be $35,105,598,195, with the lowest IRTC revenue forecast at $32,778,739,813, and the highest IRTC revenue forecast at $38,237,083,480.
In 2028, IRTC is forecast to generate $40,577,456,693 in revenue, with the lowest revenue forecast at $37,182,267,384 and the highest revenue forecast at $44,730,795,071.